Tong Ren Tang Technologies CoTGRNF 50 PE Ratio (TTM) is 11.51 as of Jul. 02, 2026, which is 14% below its 10-year median of 13.43. GuruFocus rates TGRNF with a GF Score™ of 50/100 and a GF Value™ of $0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 636 Drug Manufacturers companies, Tong Ren Tang Technologies Co ranks better than 84.59% on this metric.
During the past 12 months, Tong Ren Tang Technologies Co's average EPS without NRIGrowth Rate was -15.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -12.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -5.50% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -3.30% per year.
During the past 13 years, Tong Ren Tang Technologies Co's highest 3-Year average EPS without NRI Growth Rate was 32.20% per year. The lowest was -12.10% per year. And the median was 9.40% per year.
Tong Ren Tang Technologies Co (OTCPK:TGRNF) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Tong Ren Tang Technologies Co PE Ratio (TTM) Related Terms
Tong Ren Tang Technologies Co PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tong Ren Tang Technologies Co PE Ratio (TTM) Chart
TGRNF vs LLY, JNJ, ABBV: PE Ratio (TTM) Comparison
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co PE Ratio (TTM) vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's PE Ratio (TTM) falls into.
Tong Ren Tang Technologies Co PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Tong Ren Tang Technologies Co's Share Price of today is $0.4949.
For company reported semi-annually, Tong Ren Tang Technologies Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Tong Ren Tang Technologies Co (TGRNF) has a PE Ratio (TTM) of 11.51 as of Jul. 02, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Tong Ren Tang Technologies Co and its competitors. This is 14% below median its historical median of 13.43. Over the past decade, Tong Ren Tang Technologies Co's PE Ratio (TTM) has ranged from 8.37 to 31.25. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #98 out of 636 companies in the Drug Manufacturers industry, placing it in the top 15.4%.
Is Tong Ren Tang Technologies Co's PE Ratio (TTM) too high?
Tong Ren Tang Technologies Co's current PE Ratio (TTM) of 11.51 is 14% below median its 10-year median of 13.43. Over the past 10 years, this metric has ranged from a low of 8.37 to a high of 31.25. The Drug Manufacturers industry median PE Ratio (TTM) is 20.67. Tong Ren Tang Technologies Co's value of 11.51 is 44.3% below this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #98 out of 636 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's PE Ratio (TTM) compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #98 out of 636 companies for PE Ratio (TTM). This places Tong Ren Tang Technologies Co in the top 15% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 20.67. Tong Ren Tang Technologies Co's value of 11.51 is 44.3% below this benchmark. Historically, Tong Ren Tang Technologies Co's own PE Ratio (TTM) has ranged from 8.37 to 31.25 over the past decade. While the company's 10-year median is 13.43 vs. the industry median of 20.67, Tong Ren Tang Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Drug Manufacturers company?
The median PE Ratio (TTM) among Drug Manufacturers companies is 20.67, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current PE Ratio (TTM) of 11.51 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median PE Ratio (TTM) is 20.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current PE Ratio (TTM) is 11.51, which is 14% below median its own 10-year median of 13.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co (TGRNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.84, compared to a current price of $0.49 — trading 41.1% below its estimated fair value. The current PE Ratio (TTM) is 11.51, which is 14% below median its 10-year median of 13.43 and 44.3% below the Drug Manufacturers industry median of 20.67. Tong Ren Tang Technologies Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (TGRNF), the current PE Ratio (TTM) is 11.51 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (TGRNF) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of $0.49 is trading 41.1% below its estimated GF Value™ of $0.84.
GuruFocus considers Tong Ren Tang Technologies Co to be Significantly Undervalued.
Key valuation signals for TGRNF:
PE Ratio (TTM): 11.51 (14% below median its 10-year median of 13.43)
GF Value™: $0.84 vs. price of $0.49 (41.1% below fair value)
Industry Position: 44.3% below the Drug Manufacturers median (#98 of 636)
No single metric tells the full story. See the TGRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Business Description
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
50GF Score
Get the complete analysis for TGRNF
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGRNF has been successfully added to your 
